1. Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study
- Author
-
Toshikazu Jinnai, Hidenori Yaku, Takashi Morinaga, Moritake Iguchi, Mamoru Toyofuku, Yasutaka Inuzuka, Kenji Ando, Yuichi Kawase, Ryoji Taniguchi, Yuta Seko, Takafumi Kawai, Akihiro Komasa, Neiko Ozasa, Yusuke Yoshikawa, Ryusuke Nishikawa, Kazuya Nagao, Mamoru Takahashi, Takeshi Morimoto, Takeshi Kitai, Masashi Kato, Koichiro Kuwahara, Takao Kato, Erika Yamamoto, Takeshi Kimura, Mitsunori Kawato, Yodo Tamaki, Masayuki Shiba, Kazushige Kadota, Tomoyuki Ikeda, Yukihito Sato, and Yutaka Furukawa
- Subjects
Male ,Acute decompensated heart failure ,Epidemiology ,Physiology ,Kaplan-Meier Estimate ,Cardiovascular Medicine ,030204 cardiovascular system & hematology ,Biochemistry ,Body Mass Index ,Cohort Studies ,Medical Conditions ,0302 clinical medicine ,Outcome Assessment, Health Care ,Medicine and Health Sciences ,Medicine ,030212 general & internal medicine ,Hypoalbuminemia ,Aged, 80 and over ,Multidisciplinary ,Ejection fraction ,biology ,Hazard ratio ,Anemia ,Hematology ,Middle Aged ,Treatment Outcome ,Physiological Parameters ,Cardiovascular Diseases ,Cardiology ,Female ,Research Article ,medicine.medical_specialty ,Science ,Serum albumin ,Lower risk ,03 medical and health sciences ,Albumins ,Internal medicine ,Humans ,Acute Coronary Syndrome ,Serum Albumin ,Aged ,Heart Failure ,business.industry ,Body Weight ,Albumin ,Biology and Life Sciences ,Proteins ,Cardiovascular Disease Risk ,medicine.disease ,Medical Risk Factors ,Heart failure ,biology.protein ,business - Abstract
Background Despite the prognostic importance of hypoalbuminemia, the prognostic implication of a change in albumin levels has not been fully investigated during hospitalization in patients with acute decompensated heart failure (ADHF). Methods Using the data from the Kyoto Congestive Heart Failure registry on 3160 patients who were discharged alive for acute heart failure hospitalization and in whom the change in albumin levels was calculated at discharge, we evaluated the association with an increase in serum albumin levels from admission to discharge and clinical outcomes by a multivariable Cox hazard model. The primary outcome measure was a composite of all-cause death or hospitalization for heart failure. Findings Patients with increased albumin levels (N = 1083, 34.3%) were younger and less often had smaller body mass index and renal dysfunction than those with no increase in albumin levels (N = 2077, 65.7%). Median follow-up was 475 days with a 96% 1-year follow-up rate. Relative to the group with no increase in albumin levels, the lower risk of the increased albumin group remained significant for the primary outcome measure (hazard ratio: 0.78, 95% confidence interval: 0.69–0.90: P = 0.0004) after adjusting for confounders including baseline albumin levels. When stratified by the quartiles of baseline albumin levels, the favorable effect of increased albumin was more pronounced in the lower quartiles of albumin levels, but without a significant interaction effect (interaction P = 0.49). Conclusions Independent of baseline albumin levels, an increase in albumin during index hospitalization was associated with a lower 1-year risk for a composite of all-cause death and hospitalization in patients with acute heart failure.
- Published
- 2020